Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Ingalls & Snyder LLC

Ingalls & Snyder LLC cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 4,762 shares of the medical equipment provider’s stock after selling 273 shares during the period. Ingalls & Snyder LLC’s holdings in Intuitive Surgical were worth $2,486,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of the business. State Street Corp boosted its holdings in shares of Intuitive Surgical by 1.4% in the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after buying an additional 210,363 shares during the period. FMR LLC boosted its holdings in shares of Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after buying an additional 838,793 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Intuitive Surgical by 1.9% in the 3rd quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock valued at $3,677,194,000 after buying an additional 143,440 shares during the period. Fisher Asset Management LLC boosted its holdings in shares of Intuitive Surgical by 1.8% in the 3rd quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock valued at $2,349,441,000 after buying an additional 86,208 shares during the period. Finally, Baillie Gifford & Co. boosted its stake in Intuitive Surgical by 0.6% during the 3rd quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock valued at $1,890,676,000 after purchasing an additional 24,183 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This represents a 6.39 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,746,819.42. The trade was a 1.22 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 6,348 shares of company stock worth $3,587,582. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $589.61 on Thursday. The stock has a market cap of $210.01 billion, a P/E ratio of 91.98, a PEG ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The company has a fifty day moving average price of $556.91 and a 200 day moving average price of $516.98.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the stock. Leerink Partners boosted their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Wells Fargo & Company boosted their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. JPMorgan Chase & Co. boosted their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Bernstein Bank boosted their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a report on Monday, January 27th. Finally, Evercore ISI boosted their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.